Biogen Inc (BIIB)
218.67
-2.74
(-1.24%)
USD |
NASDAQ |
May 07, 15:19
Biogen Gross Profit (TTM): 7.250B for March 31, 2024
Gross Profit (TTM) Chart
Historical Gross Profit (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 7.250B |
December 31, 2023 | 7.302B |
September 30, 2023 | 7.507B |
June 30, 2023 | 7.676B |
March 31, 2023 | 7.917B |
December 31, 2022 | 7.895B |
September 30, 2022 | 7.996B |
June 30, 2022 | 8.224B |
March 31, 2022 | 8.434B |
December 31, 2021 | 8.872B |
September 30, 2021 | 9.160B |
June 30, 2021 | 9.820B |
March 31, 2021 | 10.78B |
December 31, 2020 | 11.64B |
September 30, 2020 | 12.50B |
June 30, 2020 | 12.74B |
March 31, 2020 | 12.61B |
December 31, 2019 | 12.42B |
September 30, 2019 | 12.24B |
June 30, 2019 | 12.04B |
March 31, 2019 | 11.84B |
December 31, 2018 | 11.64B |
September 30, 2018 | 11.40B |
June 30, 2018 | 11.13B |
March 31, 2018 | 10.90B |
Date | Value |
---|---|
December 31, 2017 | 10.64B |
September 30, 2017 | 10.34B |
June 30, 2017 | 10.17B |
March 31, 2017 | 9.982B |
December 31, 2016 | 9.970B |
September 30, 2016 | 9.984B |
June 30, 2016 | 9.913B |
March 31, 2016 | 9.695B |
December 31, 2015 | 9.524B |
September 30, 2015 | 9.359B |
June 30, 2015 | 9.100B |
March 31, 2015 | 8.924B |
December 31, 2014 | 8.532B |
September 30, 2014 | 7.896B |
June 30, 2014 | 7.280B |
March 31, 2014 | 6.644B |
December 31, 2013 | 6.074B |
September 30, 2013 | 5.651B |
June 30, 2013 | 5.304B |
March 31, 2013 | 5.093B |
December 31, 2012 | 4.971B |
September 30, 2012 | 5.613B |
June 30, 2012 | 5.287B |
March 31, 2012 | 5.113B |
December 31, 2011 | 5.054B |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (TTM) Range, Past 5 Years
7.250B
Minimum
Mar 2024
12.74B
Maximum
Jun 2020
9.752B
Average
9.016B
Median
Gross Profit (TTM) Benchmarks
Eli Lilly and Co | 28.80B |
Bristol-Myers Squibb Co | 34.48B |
Gilead Sciences Inc | 20.80B |
AbbVie Inc | 33.88B |
Sage Therapeutics Inc | 87.86M |